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The Dnmt3a DNAmethyltransferase contains in its N-termi-
nal part a PWWP domain that is involved in chromatin target-
ing. Here, we have investigated the interaction of the PWWP
domain with modified histone tails using peptide arrays and
show that it specifically recognizes the histone 3 lysine 36 tri-
methylationmark. H3K36me3 is known to be a repressivemod-
ification correlatedwithDNAmethylation inmammals andhet-
erochromatin in Schizosaccharomyces pombe. These results
were confirmed by equilibrium peptide binding studies and
pulldown experiments with native histones and purified native
nucleosomes. The PWWP-H3K36me3 interaction is important
for the subnuclear localization of enhanced yellow fluorescent
protein-fused Dnmt3a. Furthermore, the PWWP-H3K36me3
interaction increases the activity of Dnmt3a for methylation of
nucleosomal DNA as observed using native nucleosomes iso-
lated from human cells after demethylation of the DNA with
5-aza-2-deoxycytidine as substrate for methylation with
Dnmt3a. These data suggest that the interaction of the PWWP
domain with H3K36me3 is involved in targeting of Dnmt3a to
chromatin carrying thatmark, amodel that is in agreementwith
several studies on the genome-wide distribution of DNAmeth-
ylation and H3K36me3.
In mammals, DNAmethylation plays important roles in dif-
ferentiation, gene regulation, genomic imprinting, X chromo-
some inactivation, and disease-related processes (1–3). DNA
methylation patterns are set during embryogenesis by the
Dnmt3a and Dnmt3b DNAmethyltransferases and their regu-
latory factor Dnmt3L (Dnmt3-like) (4–6). However, themech-
anisms guiding these enzymes to their target regions are not
well understood. Dnmt3a and 3b consist of a C-terminal cata-
lytic domain and an N-terminal part containing a PWWP
domain and an ADD2 domain (1, 7, 8). Biochemical studies
provide evidence for a direct interaction ofDnmt3a and 3bwith
native nucleosomes (9), which could be mediated by the ADD
domain or the PWWP domain. The ADD domains of Dnmt3L
andDnmt3a have been shown to interact with the histone 3 tail
unmethylated at Lys4 (10–12), which can explain the anticor-
relation of DNA methylation and the activating H3K4me3
mark as observed in many genome-wide DNA methylation
studies (13–16). However, the ADD domain is not directly
involved in heterochromatic targeting of Dnmt3a (17, 18).
PWWP domains belong to the Royal domain superfamily,
members of which were identified to interact with histone tails
in various modification states (19). The PWWP domains of
Dnmt3a and 3b are essential for heterochromatic targeting (17,
18). An S333P missense mutation in the Dnmt3a PWWP
domain (numbering refers tomurine Dnmt3a) led to the loss of
chromatin targeting of Dnmt3a (18). This mutation corre-
sponds to the S282Pmutation in the PWWP domain of human
Dnmt3b, which has been identified in immunodeficiency, cen-
tromeric heterochromatin instability, and facial anomalies syn-
drome patients (20).
Here, we explore the possibility of the interaction of the
Dnmt3a PWWP domain with histone peptides using modified
histone tail peptide arrays. We discovered its specific interac-
tion with H3K36me3 and show that this interaction is impor-
tant for the subnuclear localization of Dnmt3a and for its cata-
lytic activity on native chromatin.
EXPERIMENTAL PROCEDURES
Cloning, Site-directed Mutagenesis, Expression, and Purifica-
tion—The sequence encoding the PWWP domain of murine
Dnmt3a (residues 279–420) was subcloned as a GST fusion
protein into the pGEX-6P2 vector (GE Healthcare) using
BamHI/XhoI sites. The GST-tagged PWWP domain and its
variantswere expressed and purified as described (21). The full-
length murine Dnmt3a2 cloned into pET28a (Novagen) vector
was used for the expression and purification of full-length
Dnmt3a2 (22), which is the predominant isoform of Dnmt3a in
embryonic stem cells (23). The catalytic domain of Dnmt3a
(Dnmt3a-CD) was expressed and purified as described (24). To
prepare the EYFP-Dnmt3a expression construct used for sub-
nuclear localization studies, Dnmt3a was cloned from a pET
expression vector (25) into pcDNA3.1, yielding pcDNA-Dnmt3a.
Then EYFP was amplified from pEYFP-C1 (Clontech) and
cloned into pcDNA-Dnmt3a in front of the Dnmt3a gene to
encode for an EGFP-Dnmt3a fusion protein.
The E290A and D329A mutations in the PWWP domain of
Dnmt3a and the D329A mutation in Dnmt3a2 and in EGFP-
Dnmt3a were introduced by using a PCR megaprimer muta-
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genesis method as described previously (26). Successful
mutagenesis and cloning was confirmed by restriction marker
site analysis and DNA sequencing.
Synthesis of Peptide SPOT Arrays—Peptide arrays were syn-
thesized on cellulose membranes using the SPOT synthesis
method (27). Each spot had diameters of 2 mm and contained
9 nmol of peptide (Autospot Reference Handbook, Intavis
AG). Successful synthesis of each peptide was confirmed by
bromphenol blue staining of the membranes. H3 26–44
K36me3 (with N-terminal fluorescein label) and unmodified
H3 26–44 peptideswere purchased from Intavis AG in purified
form.
Binding of Protein Domains to Peptides Arrays—The cellu-
lose membrane was blocked by incubation in TTBS buffer (10
mM Tris/HCl, pH 8.3, 0.05% Tween 20, and 150 mM NaCl)
containing 5% nonfat dried milk at 4 °C overnight. The mem-
brane was then washed once with TTBS buffer and incubated
with purified GST-tagged PWWP domain of Dnmt3a or
mutant domains (10 nM) at room temperature for 1 h in inter-
action buffer (100 mM KCl, 20 mMHepes, pH 7.5, 1 mM EDTA,
0.1 mM dithiothreitol, and 10% glycerol). After washing in
TTBS buffer, the membrane was incubated with goat anti-GST
antibody (GEHealthcare, catalog number 27-4577-01 at 1:5000
dilution) in TTBS buffer for 1 h at room temperature. Then the
membrane was washed three times with TTBS and incubated
with horseradish peroxidase-conjugated anti-goat antibody
(Invitrogen catalog number 81-1620 1:12000) inTTBS for 1 h at
room temperature. Finally, the membrane was submerged in
ECL developing solution (GE Healthcare), and the image was
captured in x-ray film.
Fluorescence Depolarization Peptide Binding Experiments—
Fluorescence depolarization experiments were carried out at
25 °C using a Varian Carry Eclipse fluorescence spectropho-
tometer. For the determination of the binding constant of the
PWWP domain to the fluorophore-coupled H3 K36me3 pep-
tide, 0.1 M of peptide was incubated with increasing concen-
trations of PWWP domain (0.8–60 M) in interaction buffer
(100 mM NaCl, 50 mM Tris/HCl, pH 8.0, 2 mM EDTA, 0.1%
Triton X-100), and fluorescence depolarization was deter-
mined (excitation at 494 nm, emission at 524 nm, and excita-
tion and emission slits at 5 nm). The data were fitted to a binary
binding equilibrium to determine the equilibrium binding con-
stant. For competition experiments, 30Mof fluorophore-cou-
pled H3K36me3 was incubated with 30 M of PWWP domain
in interaction buffer, and their interaction was competed by 2-
and 5-fold molar excesses of unlabeled unmodified H3 26–44
peptide.
Preparation of Native Histones and Nucleosomes—Native
histones were isolated from HEK293 cells by acid extraction as
described (28). Native nucleosomes were prepared from
HEK293 cells by partial micrococcal nuclease (New England
Biolabs) digestion of nuclei as described (29), except that after
micrococcal nuclease digestion the nuclei were removed by
centrifugation, and the supernatant containing nucleosomes
(predominantly mononucleosomes) were used (supple-
mental Fig. S3). For the preparation of demethylated nucleo-
somes, HEK293 cells were treated with 2 M 5-aza-2-deoxycy-
tidine (Sigma-Aldrich) for 72 h (corresponding to three cell
divisions under these conditions), and the cells were allowed to
recover for another 48 h in mediumwithout 5-aza-2-deoxycy-
tidine. From these cells, nucleosomes were prepared as
described above.
GST Pulldown Experiments—For GST pulldown experi-
ments, 20 l of glutathione-Sepharose 4B beads (Amersham
Biosciences) were incubated with 20 g of GST-tagged PWWP
domain of Dnmt3a or mutant domain for 1 h at 4 °C in the
interaction buffer (50mMTris/HCl, pH8.0, 100mMNaCl, 2mM
EDTA, and 0.1% Triton X-100). Then the beads were washed
once with interaction buffer and blocked with interaction
buffer containing 5% bovine serum albumin for 1 h at 4 °C. 35
g of native histones or 100 g of native oligonucleosomes
were added to the beads in interaction buffer and incubated for
3 h. Finally, the beads were washed three times with interaction
buffer, resuspended in 2 SDS-PAGE loading dye, and boiled
for 10min, and the supernatant containing the bound fractions
was separated on 16% SDS-PAGE and transferred to nitrocel-
lulose membrane. The membrane was cut in two parts. The
lower part (20 kDa) was probed with anti-H3K36me3 anti-
body (Abcam ab9050), and the upper part was probed with
anti-GST antibody (GE Healthcare) to provide a gel loading
control (supplemental Fig. S4, A and B).
For the specificity analysis, the beads were loaded with GST-
tagged PWWP domain and incubated with native oligonucleo-
somes in interaction buffer as described above, washed three
times with washing buffer (50mMTris, pH 8.0, 150mMNaCl, 2
mM EDTA, and 0.1% Triton X-100), resuspended in 2 SDS-
PAGE loading buffer and boiled for 10 min. The supernatant
was split equally and loaded on 16% SDS-PAGE gels. The sep-
arated proteins were transferred to nitrocellulose membrane
and probed with different modification specific histone anti-
bodies: anti-H3K36me3 (Abcam ab9050), anti-H3K9me3
(ActiveMotif 39161), anti-H3K4me3 (ActiveMotif 39159), and
anti-H3K27me3 (Active Motif 39535). Equal loading of bound
fractions was confirmed by Ponceau S staining of the blot prior
to the antibody staining (supplemental Fig. S4C).
Cell Culture, Transfection, and Microscopy—HEK293 and
NIH3T3 cells were grown in Dulbecco’s modified Eagle’s
medium with 5% fetal calf serum at 37 °C at 5% CO2. The
NIH3T3 cells were seeded in coverslips and transfected with
EYFP-Dnmt3a or EYFP-Dnmt3a-D329A mutant constructs
using FuGENE 6 (Roche Applied Science) according to the
manufacturer’s instructions. Two days after transfection, the
cells were fixed with 4% paraformaldehyde and embedded with
Mowiol (Carl Roth). Confocal images were taken using a Zeiss
LSM 510 Meta instrument (software version 3.0) and 63 oil
immersion objective. An argon laser line at 514 nmwas used to
excite EYFP fluorescence, and a BP530–550 filter was used for
image recording. Fluorescencemicroscopy pictures were taken
using an AXIOPLAN2 microscope equipped with AxioCam
HRc camera andAchroplan 100 oil immersion objective with
filter sets 4,6-diamino-2-phenylindole FT395/LP420 and
green fluorescent protein BP450–490/FT510 (all from Carl
Zeiss).
In VitroMethylation of Native Chromatin—Themethylation
reactions were performed with either Dnmt3a2 enzyme,
Dnmt3a2-D329A mutant, or Dnmt3a-CD in methylation
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buffer (20 mM Hepes, pH 7.5, 2 mM EDTA, and 50 mM KCl)
containing 0.75 M radioactively labeled S-adenosyl-L-methio-
nine (PerkinElmer Life Sciences) and 1 g of demethylated
native chromatin in 25 l of total reaction volume. Additional
methylation experiments were conducted in the presence of
anti-H3K36me3 antibody (Abcam ab9050), anti-H3K9me3
antibody (Active Motif 39161), anti-H3K4me3 antibody
(Active Motif 39159), or anti-H3K27me3 antibody (Active
Motif 39535) all in 1:5000 final dilution. The methylation reac-
tions were incubated at 37 °C for 2 h, and the reactions were
stopped by the addition of excess of unlabeled S-adenosyl-L-
methionine. Then the reactionmixtures were subjected to pro-
teinase K (New England Biolabs) digestion at 42 °C for 2 h, and
the nucleic acids in the reaction mixture were purified using
Nucleospin PCR purification (Machery Nagel). The amount of
radioactivity incorporated into the DNA was measured by liq-
uid scintillation counting and normalized with respect to the
total amount of DNA as determined by UV spectroscopy.
Methylation of biotinylated oligonucleotide substrates by
Dnmt3a2 and its variants was studied bymeasuring the transfer
of titrated methyl groups from labeled S-adenosyl-L-methio-
nine into biotinylated oligonucleotides (Bt-GAG AAG CTG
GGA CTT CCG GGA GGA GAG
TGC/GCA CTC TCC TCC CGG
AAG TCC CAG CTT CTC) using
the avidin-biotin methylation assay
as described (22, 30).
RESULTS
Peptide Array Binding and Struc-
tural Modeling—To investigate
whether the Dnmt3a PWWP do-
main interacts with modified his-
tone peptides, we employed two dif-
ferent modified histone tail peptide
arrays containing in total more than
1000 peptides in various combina-
tions of known and hypothetical
modification states of the H3, H4,
H2A, and H2B tails. We repeatedly
observed that the GST-tagged
PWWP domain of Dnmt3a inter-
acted with the histoneH3 K36 trim-
ethylation mark with high specific-
ity (Fig. 1).
Binding to trimethylated lysine
usually involves hydrophobic cages,
which often have an acidic residue
nearby (19). Because the PWWP
domains from Dnmt3a and 3b
share high amino acid homology,
we used the structure of the
Dnmt3b PWWP domain (31) to
model the structure of the Dnmt3a
PWWP domain and identify such
potential binding pockets next to
Glu290 and Asp329 (supplemental
Fig. S1). Trying to disrupt the histone
interaction of PWWP, we mutated Glu290 and Asp329 to alanine.
These residues are both exposed on the surface of the Dnmt3a
PWWP structural model, suggesting that their exchange will not
affect the overall domain structure.We did notmutate the buried
hydrophobic residues of the predicted pockets to avoid effects on
protein folding and stability. The mutant domain proteins could
be expressed and purified with similar yields as the wild type
domain (supplemental Fig. S2A), andCD spectroscopy confirmed
the wild type-like folding of the D329A mutant domain
(supplemental Fig. S2B). Binding experiments on peptide arrays
showed that there was no significant change in the peptide
interaction of the E290A variant, but the D329A variant had
completely lost its ability to bind specifically to the H3K36me3
peptide (Fig. 1B).
Recently, the structure of the Eaf3 chromobarrel domainwas
solved in complex with an H3K36me2 analog (32). Over 144
backbone atoms comprising the conserved -barrel and the
adjacent -helix fold, the Eaf3 chromo barrel domain structure
could be superimposed with the mouse Dnmt3b PWWP
domain structure with a root mean square deviation of 1.37 Å
(supplemental Fig. S1). The overlay positioned the methylated
Lys36 residue immediately adjacent to Asp329 in the Dnmt3a
FIGURE 1. Peptide binding by the Dnmt3a wild type PWWP domain and its variants. A, interaction of the
wild type PWWP domain with histone tail arrays containing different combinations of 107 known and hypo-
thetical modifications at the H3, H4, H2A, H2B, and H1b histone tails. The isolated GST domain does not interact
with peptide arrays (data not shown). The spot corresponding to the H3 29 – 46 K36me3 peptide is indicated
with an arrow; some other spots that do not interact with the PWWP domain are labeled with numbers and
annotated below the image. B, interaction of wild type PWWP domain, D329A, and E290A variants with mod-
ified histone tails. The H3K36me3 and H3K36me2 spots on the different arrays used for this study are high-
lighted with black and gray arrows, respectively. C, binding of the H3K36me3 peptide to PWWP domain studied
by fluorescence depolarization (black diamonds). The line represents a fit of the data to a binary binding
equilibrium, which revealed a Kd of 64 M. The gray squares display changes in fluorescence depolarization
observed after adding same volumes of buffer. D, weak competition of H3K36me3 peptide binding to the
PWWP domain by the addition of unmethylated H3K36 peptide confirms specific binding.
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PWWPdomainmodel. This observation indicates that the bio-
chemical data obtained here are compatible with the structural
results obtainedwith related domains. Furthermore, theAsp329
residue is close to the Ser333 residue (supplemental Fig. S1),
mutation of which leads to loss of heterochromatic localization
(18).
Equilibrium Peptide Binding Experiments—The interaction
of the PWWP domain with H3K36me3 was confirmed by fluo-
rescence depolarization using a fluorescently labeledH326–44
K36me3 peptide (Fig. 1C). The binding constant was deter-
mined as 64 M, which is weak but in the range of results
observed with other individual chromatin-binding domains,
like BHC80 Plant Homeodomain like domain binding to
H3K4me0 peptide: 33 M (33), L3MBTL1 to the H3K9me1
peptide: 26 M (34), BRD2 bromodomain 1 to the H4K5ac/
K12ac peptide: 360 M (35), and Brd4 bromodomain 1 binding
to H3K14ac: 118 M (36). Peptide binding of the PWWP-
D329A variant was at least five times weaker (data not shown).
To assess the binding specificity, binding was competed with
unmodified H3 26–44 peptide (Fig. 1D). We observed that at a
5-fold excess of competitor only 20% of binding was lost, cor-
responding to a 25-fold preference for binding to the methyl-
ated peptide.
Nucleosome and Histone Pulldown Experiments—The
PWWP-H3K36m3 interaction was also confirmed by pull-
down experiments. The GST-PWWP domain of Dnmt3a
was able to pull down native nucleosomes isolated from
human cells, which contained the H3K36me3 mark (Fig. 2A
and supplemental Figs. S3A and 4A). In contrast, the PWWP-
D329A mutant completely failed to interact with nucleosomes
(Fig. 2A and supplemental Fig. S4A). In addition to H3K36me3,
the nucleosome fraction bound by the PWWPdomain was also
enriched with H3K9me3, but the amounts of H3K4me3 and
H3K27me3 were reduced in comparison with H3K36me3 (Fig.
2B). The relative reduction in the amounts of H3K4me3 and
K27me3 indicates that the pulldown is specific. The pres-
ence of the H3K9me3mark in the pull down was expected on
the basis of the overlapping distribution profiles of the
H3K36me3 and H3K9me3 marks across transcribed chro-
matin (37). Using native histones isolated from human cells
(supplemental Fig. S3B), we observed that the GST-PWWP
domain of Dnmt3a, but not its D329A mutant, interacted with
histone H3K36me3 mark (Fig. 2C and supplemental Fig. S4B),
indicating that the interaction does not require DNA.
Subnuclear Localization of Dnmt3a—We investigated the
subnuclear distribution of the EYFP-fused Dnmt3a and its
D329Amutant inNIH3T3 cells after transient expression of the
proteins. Both proteins were located in the nucleus, which was
expected because the nuclear localization signals ofDnmt3a are
outside of the PWWP domain (17). Within the nucleus,
Dnmt3a was found in large spots corresponding to 4,6-di-
amino-2-phenylindole-stained heterochromatin as reported
earlier (17, 18) (Fig. 3 and supplemental Fig. S5). In contrast, the
mutant protein was found more homogenously distributed in
the nucleus, indicating a partial loss of heterochromatic local-
ization. This result suggests that the interaction of PWWPwith
K36me3 is important for the localization of Dnmt3a to
heterochromatin.
DNA Methylation Experiments—The influence of the
PWWP-H3K36me3 interaction on the methylation of nucleo-
somal DNA by Dnmt3a was investigated using native nucleo-
somes from human cells prepared after treatment of the cells
with 5-aza-2-deoxycytidine. This treatment reduces DNA
methylation at unique sequences and repeats bymore than 50%
(15, 38). The native nucleosomes carry their endogenous his-
tone modification pattern and partially demethylated DNA.
This experimental design allowed us to study the methylation
activity of Dnmt3a using a substrate that mimics the in vivo
FIGURE 2. Native chromatin and histone binding of the Dnmt3a PWWP
domain and its variants. A, GST pulldown assay interaction analysis of the
PWWP domain and the D329A variant with mononucleosomes purified from
human cells. The bound proteins were separated and immunoblotted with
anti-H3K36me3 antibody. B, for specificity analysis, the bound fractions were
separated and immunoblotted with anti-H3K36me3 antibody, anti-H3K4me3
antibody, anti-H3K9me3 antibody, and H3K27me3 antibody. C, GST pull-
down interaction analysis of PWWP domain and D329A mutant domain with
native histone proteins, purified from human cells. The bound fractions were
separated and immunoblotted with anti-H3K36me3 antibody. In A–C, all of
the bands correspond to histone H3.
FIGURE 3. Subnuclear distribution of wild type EYFP-Dnmt3a and EYFP-
Dnmt3a-D329A mutant in NIH3T3 cells. The subnuclear localization pat-
terns were analyzed by laser scanning microscopy and assigned into one of
the following categories: localization mainly homogenous, homogenous
localization with some large spots, and localization almost exclusively in large
spots. The figure shows examples of each type of localization patterns and
gives the distribution of occurrence of the different patterns in both experi-
ments in 100 arbitrarily chosen cells.
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situation. Demethylated nucleosomes were methylated with
Dnmt3a2, a shorter isoform of Dnmt3a lacking the N-terminal
variable region (23), the Dnmt3a2 D329A mutant (Dnmt3a2-
D329A), and the catalytic domain of Dnmt3a (Dnmt3a-CD)
using radioactively labeled S-adenosyl-L-methionine as co-
factor. The amounts of Dnmt3a2, Dnmt3a2-D329A, and
Dnmt3a-CD enzymes used in the nucleosome methylation
experiments were normalized to have similar activity on oligo-
nucleotide substrates (supplemental Fig. S6). Using the native
chromatin as substrate, we observed that Dnmt3a2 is2.5-fold
more active thanDnmt3a-CD (Fig. 4 and supplemental Fig. S6).
The Dnmt3a2 enzyme containing the mutated D329A-
PWWP domain, which fails to interact with the H3K36me3
mark, only showed a basal level of activity similar to
Dnmt3a-CD (Fig. 4).
To confirm that the increase in activity of the wild type
Dnmt3a2 is due to the PWWP-H3K36me3 interaction, we per-
formed the chromatin methylation experiments in the pres-
ence of an anti-H3K36me3 antibody. Although the addition of
the anti-H3K36me3 antibody had no effect on the activity of
Dnmt3a2-D329A or Dnmt3a-CD, it decreased the activity
of Dnmt3a2 to a basal level, similar to the level of activity
observed with the Dnmt3a2-D329A or Dnmt3a-CD (Fig. 4).
Additional unrelated antibodies used as controls had no
effect or a very weak effect on the catalytic activity of Dnmt3a2
(supplemental Fig. S6). Taken together, these results demon-
strate that the PWWP domain-H3K36me3 interaction
increases the activity of Dnmt3a2 for methylation of native
nucleosomal DNA.
DISCUSSION
We show here that the Dnmt3a PWWP domain specifically
interacts with H3 tails containing the K36me3 mark. Peptide
binding is weak but in the range of binding constants seen with
other individual domains interacting with histone peptides. In
the cell binding may be further supported by an interaction of
the PWWP domain with DNA, because the Lys36 position of
the H3 tail is very close to the DNA, such that the PWWP
domain could interact with both epitopes simultaneously.
Interestingly, the DNA binding and peptide binding properties
of the PWWPdomains fromDnmt3a and 3b seem to be inverse;
we detected peptide binding of the Dnmt3a-PWWP domain
but not for Dnmt3b (data not shown), whereas DNA binding of
the Dnmt3b-PWWP domain has been reported to be stronger
than that of Dnmt3a (17).
We show that the H3K36me3-PWWP interaction mediates
chromatin binding, because the heterochromatic localization
of Dnmt3a was disturbed in the D329A mutant, which no
longer binds to H3K36me3. Targeting of Dnmt3a by an
H3K36me3-PWWP interaction is in agreement with previous
results showing that the Dnmt3a PWWP domain is necessary
for heterochromatic localization of Dnmt3a (17, 18). In con-
trast, the ADD domain of Dnmt3a, which binds to H3 tails
unmethylated at Lys4 (11, 12), does not have a role in hetero-
chromatic localization (17, 18).
We show that the PWWP-H3K36me3 interaction stimulates
the methylation activity of Dnmt3a on chromatin-bound DNA
isolated from human cells, because the catalytic activity of the
D329Amutant dropped to levels similar to the isolated catalytic
domain. This result suggests an important role for the PWWP
domain in guiding DNAmethylation to chromatin carrying the
H3K36me3 mark, which is in agreement with the observation
that the PWWP domain is required for the activity of Dnmt3a
in the cell (17, 39). This model is further supported by the
observation that the genome-wide distribution of DNA meth-
ylation is very similar to that of K36me3 methylation. Many
studies have found that H3K36me3 accumulates in euchroma-
tin in the body of active genes, and its distribution is anticorre-
lated with H3K4me3 (37, 40–43). Similarly, active genes
showed high DNA methylation in the gene bodies, whereas
inactive genes did not (44, 45). The strong correlation of DNA
methylation, absence ofH3K4me3, and presence ofH3K36me3
were also observed in two recent genome-wide studies (14, 16).
Additionally, a correlation of H3K36me3 and DNA methyla-
tion was observed at exon-intron boundaries where exons were
FIGURE 4. A, methylation of demethylated native nucleosomes by Dnmt3a enzymes. Relative methylation activity of Dnmt3a2, Dnmt3a2-D329A, and
Dnmt3a-CD on demethylated native nucleosomes in the absence (dark gray bars) and the presence (light gray bars) of anti-H3K36me3 antibody. The error bars
indicate standard deviations derived from at least three independent experiments. B, schematic picture showing how the H3 tail interactions of the Dnmt3a
ADD domain (dark grey rectangle) binding to the end of the H3 tail (12) and the PWWP domain (light grey hexagon) binding to Lys36 (black triangle) may anchor
the catalytic domain of the enzyme (dark grey oval) to methylate DNA preferentially in linker region (12).
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shown to have increased levels of both H3K36me3 (46) and
DNA methylation (16).
Like DNA methylation, H3K36me3 is a silencing mark that
recruits histone deacetylation and represses intragenic tran-
scriptional initiation (47). Consequently, the Smyd2 histone
methlyltransferase (which generates K36me2) has a repressive
effect on reporter gene expression (48). In Schizosaccharomyces
pombe the Set2 histone methyltransferase methylates histone
H3 lysine 36 at repeat loci during the S phase (49). Conse-
quently, heterochromatic H3K36me3 transiently peaks in
the S phase and has an important role in the re-establish-
ment of heterochromatin after DNA replication that acts in a
pathway parallel to Clr4. It has been proposed that in mam-
mals Dnmt3a contributes to the maintenance of the DNA
methylation at highly methylated regions (like repeats) (50).
H3K36 methylation is an evolutionarily conserved mark,
suggesting that a transient methylation of H3K36 might
occur in mammalian genomes as well and that transient
H3K36 methylation might be one of the modifications that
recruit Dnmt3a to heterochromatin.
Dnmt3a has been shown to bind tightly to chromatin (9).
When combined with the previous findings, our data indicate
that there are several mechanisms that contribute to the inter-
action of Dnmt3a with chromatin; Dnmt3a is engaged in two
interactions with the H3 tail, mediated by its ADD domain,
which binds to the endof theH3 tail unmodified at Lys4 (11, 12),
and by its PWWP domain, which interacts with H3K36me3
located at the more basal region of the H3 tail (Fig. 4B). The
anticorrelation of the H3K4me3 and H3K36me3 marks sug-
gests that in the cell most H3 tails will either bind to both ADD
andPWWPor neither of them, such that the targeting effects of
both domains are synergistic. In addition, the catalytic domain
of Dnmt3a binds toDNA and polymerizes on theDNA (22, 51),
and it interacts with many other proteins including Dnmt3L
and Dnmt3b (52), which provide additional contact points to
chromatin (10, 53), suggesting that a complex network of inter-
actions is involved in targeting DNA methylation.
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